<SEC-DOCUMENT>0001104659-23-126050.txt : 20231214
<SEC-HEADER>0001104659-23-126050.hdr.sgml : 20231214
<ACCEPTANCE-DATETIME>20231214163333
ACCESSION NUMBER:		0001104659-23-126050
CONFORMED SUBMISSION TYPE:	FWP
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20231214
DATE AS OF CHANGE:		20231214

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Surgery Partners, Inc.
		CENTRAL INDEX KEY:			0001638833
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-GENERAL MEDICAL & SURGICAL HOSPITALS, NEC [8062]
		IRS NUMBER:				473620923
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		FWP
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	333-252399
		FILM NUMBER:		231487485

	BUSINESS ADDRESS:	
		STREET 1:		310 SEVEN SPRINGS WAY
		STREET 2:		SUITE 500
		CITY:			BRENTWOOD
		STATE:			TN
		ZIP:			37027
		BUSINESS PHONE:		615-234-5900

	MAIL ADDRESS:	
		STREET 1:		310 SEVEN SPRINGS WAY
		STREET 2:		SUITE 500
		CITY:			BRENTWOOD
		STATE:			TN
		ZIP:			37027

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Surgery Partners, Inc.
		CENTRAL INDEX KEY:			0001638833
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-GENERAL MEDICAL & SURGICAL HOSPITALS, NEC [8062]
		IRS NUMBER:				473620923
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		FWP

	BUSINESS ADDRESS:	
		STREET 1:		310 SEVEN SPRINGS WAY
		STREET 2:		SUITE 500
		CITY:			BRENTWOOD
		STATE:			TN
		ZIP:			37027
		BUSINESS PHONE:		615-234-5900

	MAIL ADDRESS:	
		STREET 1:		310 SEVEN SPRINGS WAY
		STREET 2:		SUITE 500
		CITY:			BRENTWOOD
		STATE:			TN
		ZIP:			37027
</SEC-HEADER>
<DOCUMENT>
<TYPE>FWP
<SEQUENCE>1
<FILENAME>tm2332214d7_fwp.htm
<DESCRIPTION>FWP
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Filed Pursuant to Rule&nbsp;433</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Registration Statement No.&nbsp;333-252399</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><IMG SRC="tm2332214d7_img001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SURGERY PARTNERS,&nbsp;INC. ANNOUNCES PROPOSED
SECONDARY OFFERING OF COMMON STOCK</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">BRENTWOOD, Tenn., December&nbsp;14, 2023 (GLOBE
NEWSWIRE) Surgery Partners,&nbsp;Inc. (Nasdaq: SGRY) (&ldquo;Surgery Partners&rdquo; or the &ldquo;Company&rdquo;) today announced that
certain of the Company&rsquo;s stockholders (the &ldquo;Selling Stockholders&rdquo;) intend to offer for sale in an underwritten secondary
offering (the &ldquo;Offering&rdquo;) 8,000,000 shares of the Company&rsquo;s common stock, par value $0.01 per share. The offering
is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to
the actual size or terms of the offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Selling Stockholders will receive all of the
net proceeds from this Offering. No shares are being sold by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Jefferies LLC
is acting as the sole underwriter of the Offering. The underwriter proposes to offer the shares from time to time for sale in one
or more transactions on the Nasdaq Global Select Market, in the over-the-counter market, through negotiated transactions or otherwise
at market prices prevailing at the time of sale, at prices related to prevailing market prices or at negotiated prices, subject to its
right to reject any order in whole or in part.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The shares in the underwritten public offering
are being offered pursuant to an effective shelf registration statement (including a prospectus) that was previously filed with the Securities
and Exchange Commission (the &ldquo;SEC&rdquo;) to which this communication relates. Before you invest, you should read the prospectus
in the shelf registration statement and other documents the Company has filed with the SEC for more complete information about the Company
and the Offering. The Offering will be made only by means of a written prospectus and related prospectus supplement that form a part
of the registration statement. An electronic copy of the prospectus and related prospectus supplement relating to the Offering, when
filed, will be available on the SEC&rsquo;s website at www.sec.gov and may also be obtained, when available, by contacting Jefferies
LLC, at Attention: Equity Syndicate Prospectus Department, 520 Madison Avenue, New York, New York 10022, by telephone at 877-821-7388,
or by email at <U>prospectus_department@Jefferies.com</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This press release shall not constitute an offer
to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or other
jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities
laws of any such state or other jurisdiction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><U>About Surgery Partners</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Headquartered in Brentwood, Tennessee, Surgery
Partners is a leading healthcare services company with a differentiated outpatient delivery model focused on providing high quality, cost
effective solutions for surgical and related ancillary care in support of both patients and physicians. Founded in 2004, Surgery Partners
is one of the largest and fastest growing surgical services businesses in the country, with more than 180 locations in 31 states, including
ambulatory surgery centers, surgical hospitals, multi-specialty physician practices and urgent care facilities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; border: white 1.5pt solid"><B><U>Forward-Looking
Statements</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This press release contains forward-looking statements,
including but not limited to, statements relating to Surgery Partners&rsquo; expectations regarding the completion, timing and size of
the proposed public offering. These statements can be identified by the use of words such as &ldquo;believes,&rdquo; &ldquo;anticipates,&rdquo;
 &ldquo;expects,&rdquo; &ldquo;intends,&rdquo; &ldquo;plans,&rdquo; &ldquo;continues,&rdquo; &ldquo;estimates,&rdquo; &ldquo;predicts,&rdquo;
 &ldquo;projects,&rdquo; &ldquo;forecasts,&rdquo; and similar expressions, though not all forward-looking statements use these words or
expressions. All forward-looking statements are based on current expectations and beliefs as of the date of this release and are subject
to risks, uncertainties and assumptions that could cause actual results to differ materially from those discussed in, or implied by, the
forward-looking statements, including, but not limited to, the risk that Surgery Partners may be unable to complete the proposed public
offering on the anticipated terms or at all, and the other risks identified in Item 1A under the heading &ldquo;Risk Factors&rdquo; in
the Company's Annual Report on Form&nbsp;10-K for the year ended December&nbsp;31, 2022, filed on March&nbsp;1, 2023 and the Company's
Quarterly Reports on Form&nbsp;10-Q for the quarters ended March 31, 2023, June 30, 2023 and September 30, 2023, filed on May 2, 2023, August 1, 2023 and November 7, 2023, respectively. Except as required by law, Surgery Partners does not undertake any obligation to revise or update publicly any forward-looking
statements to reflect events or circumstances after the date of this report, or to reflect the occurrence of unanticipated events or circumstances.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><U>Contact:</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Surgery Partners Investor Relations</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(615) 234-8940</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">IR@surgerypartners.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>tm2332214d7_img001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2332214d7_img001.jpg
M_]C_X  02D9)1@ ! 0$ 9 !D  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  \ =@# 2(  A$! Q$!_\0
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ME8'_ )>K&Z%^/H=I8_\ CQX[5J>=#_SV_P#'C_A0!8HJ**6*4$QL"!Z#%2T
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M?C2?''Q.T_1-:V*TWB%@SD$A0[JDWA(_\LXIFPC?9_\ P4'T$>!O^"=OQ?\
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MRR^-W@SQ(W0Y"Z!H7B-O$;$(2#E&VJ2>#S7@/P)\"_&'_@IAXK^$'[5_QO\
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M-<UKQ^2!GPWDG&A:*W (PIR0*_IRK^5W]DW]L2^_99^*O[9UC!\"/BC\8O\
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MW?>.,XQCYNG-?U$_P?\  ?Z5^(5Y_P IPM/_ .R#-_ZAFOT >P>&_P#@DO\
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M6G@(/:75M>MIKJ6UG0U!&L,/W9.3E^"X+*5[U\__ /!0KX7?$K3+3P/^UO\
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M16!KWAW2/$FE:AHNN:3INLZ3J<>R\TS5;(:EIE\'56VZKI,B".0$HN>S$*7
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M9U^'GP/^&OA3XE? CX3>-/'NE>&]/'C/Q'XL\"^#/$&K7_BK6776O$*_VO-
MY<)K\DFA1E2#*+=-N^"4L?7_ !+^P9^Q]XBT#6M#N/V;O@WI=OKVC:AHEQ>:
M#\/O!VGZI8:8P^9=$UI/#X.B,2,YC"*,D?,5:OLQ.A^O]!3Z /Q)_P""8_C^
M^^"WBSXS?\$^_B9JK'QO\&O&OB+7/A:MT%)U_P"%^M2*Z'0BSH%V.J^*W(W%
MHO'KQHC/X2\7E>V\>3?\;G_@O^_ML?\ #)>J8'?/]M?%WO\ _7/.>N*_423P
M)X4D\2CQE_PBOAS_ (2<67V,>*AHFD?\)0%[ :SM\P*/3'!R!A0!5J3PAX?E
MU^'Q7)H>ES^*;>R-DGB)M'TMO$0TX\G2?[8*JZQACDH'";?NL,ER 5?&/@O0
M?B'X7\0>#O%^C6NM>%_$^DZKHFLZ5=8*W^EZR?WB-SA<#(P2"&P<';@_C#^R
M7XD\=?L.?M"ZO^Q9\<]:O#\(/'M_J>K?LK^.]5N GAMXXYRC>"SK<ZJNA:V1
M_9!7PT PD\6222VCL)D=_P!UX_N+]*X;Q#X,\->*9M'GU_0M$UR?0KUKO1KC
M5](TG43I\A4/_P 2H2H9(3@1G<.7;206C)*2, =Y7XBW<T(_X+?V'[[!_P"%
M$-QGCGP:<#\0?UK]LO(]_P!?_K5R/_"%>&?^$@_X3#_A'-#_ .$M^Q_V?_PE
M7]C:3_PDO]G9SY?]L[-VW_9^[LXV;: .VK\0_P#@JE-!#^T7_P $UQ/-C_B_
M<O'&<_\ "<_ ;G\?O<=<_2OV\KA-<\&^&_$MY83Z]X>\/:U/H=VMWHEQK^CZ
M7J3Z%?,AP^E;T$D$FY-*P0REE5<NTFU4 .JEB\_C),%SC('7\?3.3W]*_F:_
MX*'_ +,?Q/\ V9=3^*_Q?_9YBN[;]GKXW>&=8\,_&KP/IPVV'A?4=8D\B37C
MH/EQH-!248\(^(D426;R>(XKF.W\$OY/C'^G:N:U/2++6=/U#3-5LK34M/U&
MS%G>V.IVO]HZ;?6!R&1]&W;"I+ ;608.&ZXP ?.G[$,T'_#'G[,!/(_X4/\
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M- \*Z=;Z'X>TK3M%TJR0K8Z7I-FNG:?9Y,F\!4[M_:9; 4 XP%4@J #\I/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
F4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!_]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
